Trial Profile
Efficacy and safety of Sofosbuvir in combination with Ribavirin in HIV infected male patients with early hepatitis C infection
Status:
Completed
Phase of Trial:
Phase IV
Latest Information Update: 03 Apr 2017
Price :
$35
*
At a glance
- Drugs Sofosbuvir (Primary) ; Ribavirin
- Indications Hepatitis C
- Focus Adverse reactions; Therapeutic Use
- 03 Apr 2017 New trial record
- 10 Feb 2017 Results published in the HIV Clinical Trials